Notably, astrocyte activation has also been noted in ALS patients, where it may significantly impact the progression of ALS by mediating the SQSTM1/p62-Nrf2 antioxidative stress pathway [155]. Here, SQSTM1 is linked to amyotrophic lateral sclerosis.